Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase

Journal of Clinical Investigation

Volumn 97, Issue 12, 1996, Pages 2784-2791

  Stafforini, Diana M ^a   Satoh, Kei ^c   Atkinson, Donald L ^a   Tjoelker, Larry W ^d   Eberhardt, Chris ^d   Yoshida, Hidemi ^c   Imaizumi, Tada Atsu ^c   Takamatsu, Shigeru ^c   Zimmerman, Guy A ^b   McIntyre, Thomas M ^b   Gray, Patrick W ^d   Prescott, Stephen M ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c HIROSAKI UNIVERSITY   (Japan)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

children; inflammation; Japanese population; phospholipase A2; severe asthma

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; DNA;

ARTICLE; ASTHMA; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 6P; ENZYME DEFICIENCY; ESCHERICHIA COLI; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL;

EID: 8944233858     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118733     Document Type: Article

References (46)

1. Prescott, S.M., G.A. Zimmerman, and T.M. McIntyre. 1990. Platelet-activating factor. J. Biol. Chem. 265:17381-17384.
2. Snyder, F. 1987. Platelet-activating factor and related lipid mediators. Plenum Press, New York.
3. Zimmerman, G.A., S.M. Prescott, and T.M. McIntyre. 1992. Platelet-activating factor (PAF): a fluid phase and cell-associated mediator of inflammation. In Inflammation: Basic Principles and Clinical Correlates. J.I. Gallin, I.M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 149-176.
4. Imaizumi, T.-a., D.M. Stafforini, Y. Yamada, T.M. McIntyre, S.M. Prescott, and G.A. Zimmerman. 1995. Platelet-activating factor: a mediator for clinicians. J. Int. Med. 238:5-20.
5. Farr, R.S., C.P. Cox, M.L. Wardlow, and R. Jorgensen. 1980. Preliminary studies of an acide-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin. Immunol. Immunopathol. 15:318-330.
6. Blank, M.L., T.-c. Lee, V. Fitzgerald, and F. Snyder. 1981. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phopshocholine (a hypotensive and platelet-activating lipid). J. Biol. Chem. 256:175-178.
7. Lee, T.-c., B. Malone, S.I. Wasserman, V. Fitzgerald, and F. Snyder. 1982. Activities of enzymes that metabolize platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem. Biophys. Res. Commun. 105:1303-1308.
8. Stafforini, D.M., T.M. McIntyre, M.E. Carter, and S.M. Prescott. 1987. J. Biol. Chem. 262:4215-4222.
9. Stremler, K.E., D.M. Stafforini, S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre. 1989. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. J. Biol. Chem. 264:5331-5334.
10. Yanoshita, R., I. Kudo, K. Ikizawa, H.W. Chang, S. Kobayashi, M. Ohno, S. Nojima, and K. Inoue. 1988. Hydrolysis of platelet-activating factor and its methylated analogs by acetylhydrolases. J. Biochem. 103:815-819.
11. Stafforini, D.M., S.M. Prescott, G.A. Zimmerman, and T.M. McIntyre. 1991. Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids. 26:979-985.
12. Hattori, M., H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue. 1994. The catalytic subunit of bovine brain platelet-activating factor acetylhydrolase is a novel type of serine esterase. J. Biol. Chem. 269:23150-23155.
13. Hattori, M., H. Arai, and K. Inoue. 1993. Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 268:18748-18753.
14. Stafforini, D.M., E.N. Rollins, S.M. Prescott, and T. M. McIntyre. 1993. The platelet-activating factor acetylhydrolase from human erythrocytes. Purification and properties. J. Biol. Chem. 268:3857-3865.
15. Stafforini, D.M., S.M. Prescott, and T.M. McIntyre. 1987. Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J. Biol. Chem. 262:4223-4230.
16. Tjoelker, L.W., C. Wilder, C. Eberhardt, D.M. Stafforini, G. Dietsch, B. Schimpf, S. Hooper, H.L. Trong, L.S. Cousens, G.A. Zimmerman, Y. Yamada, T. M. McIntyre, S.M. Prescott, and P.W. Gray. 1995. Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature (Lond.). 374: 549-552.
17. 2 with a catalytic triad. J. Biol. Chem. 270:25481-25487.
18. Hattori, M., H. Adachi, J. Aoki, M. Tsujimoto, H. Arai, and K. Inoue. 1995. Cloning and expression of a cDNA encoding the β-subunit (30 KDa Subunit) of bovine brain platelet-activating factor acetylhydrolase. J. Biol. Chem. 270:31345-31352.
19. Hattori, M., H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue. 1994. Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase. Nature (Lond.). 370:216-218.
20. Hattori, M., K. Hattori, H. Adachi, M. Tsujimoto, H. Arai, and K. Inoue. 1995. Purification and characterization of platelet-activating factor acetylhydrolase II from bovine brain liver cytosol. J. Biol. Chem. 270:22308-22313.
21. Tetta, C., F. Bussolino, V. Modena, G. Montrucchio, G. Segoloni, G. Pescarmona, and G. Camussi. 1990. Release of platelet-activating factor in systemic lupus erythematosus. Int. Arch. Allergy Appl. Immunol. 91:244-256.
22. Tsukioka, K., M. Matsuzaki, M. Nakamata, and H. Kayahara. 1993. Increased plasma levels of platelet-activating factor (PAF) and low serum PAF acetylhydrolase (PAF-AH) activity in adult patients with bronchial asthma. Arerugi. 42:167-171.
23. Hsieh, K.-H., and C.-K. Ng. 1993. Increased plasma platelet-activating factor in children with acute asthmatic attacks and decreased in vivo and in vitro production of platelet-activating factor after immunotherapy. J. Allergy Clin. Immunol. 91:650-657.
24. Miwa, M., T. Miyake, T. Yamaoka, S. Sugatani, Y. Suzuki, S. Sakata, Y. Araki, and M. Matsumoto. 1988. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82:1983-1991.
25. Kunkel, L.M., K.D. Smith, S.H. Boyer, D.S. Borgaonkar, S.S. Wachtel, O.J. Miller, W.R. Breg, H.W. Jones, and J.M. Rary. 1977. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc. Natl. Acad. Sci. USA. 74:1245-1249.
26. Sambrook, J., E.F. Frilsch and I. Maniatis. 1982. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor, New York. Cold Spring Harbor Laboratory Press.
27. Saiki, R.K., D.H. Gelfand, S. Stoffel, S.J. Scharf, R. Higuchi, G.T. Horn, K.B. Mullis, and H.A. Erlich. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (Wash. DC). 239:487-491.
28. Marchuk, D., M. Drumm, A. Saulino, and F.S. Collins. 1991. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 19:1154.
29. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Nat. Acad. Sci. USA. 74:5463-5467.
30. Stafforini, D. M., T. M. McIntyre, and S. M. Prescott. 1990. Platelet-activating factor acetylhydrolase from human plasma. Methods Enzymol. 187:344-357.
31. Miyaura, S., H. Eguchi, and J.M. Johnston. 1992. Effect of a cigarette smoke extract on the metabolism of the proinflammatory autacoid, platelet-activating factor. Circ. Res. 70: 341-347.
32. Graham, R.M., C.J. Stephens, W. Silvester, L.L. Leong, M.J. Strurm, and R.R. Taylor. 1994. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit. Care Med. 22:204-212.
33. Ninan, T.K., and G. Russell. 1992. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. Br. Med. J. 304:873-875.
34. Robertson, C.F., E. Heycock, J. Bishop, T. Nolan, A. Olinsky, and P.D. Phelan. 1991. Prevalence of asthma in Melbourne schoolchildren: change over 26 years. Br. Med. J. 302:1116-1118.
35. Myers, P., and L.P. Ormerod. 1992. Increased asthma admission rates in Asian patients: Blackburn 1987. Resp. Med. 86:297-300.
36. Leung, R., and P. Ho. 1994. Asthma, allergy, and atopy in three Southeast Asian populations. Thorax. 49:1205-1210.
37. Sherman, C.B., T.D. Tostenson, I.B. Tager, F.E. Speizer, and S. Weiss. 1990. Early childhood predictors of asthma. Am. J. Epidemiol. 132:83-88.
38. Jenkins, M.A., J.L. Hopper, and G.G. Giles. 1993. A population based family study of asthma. Proceedings of Thirteenth Scientific Meeting of International Epidemiological Association. 63 pp.
39. Miletich, J.P., S.M. Prescott, R. White, P.W. Majerus, and E.G. Bovill. 1993. Inherited predisposition to thrombosis. Cell. 72:477-480.
40. Miletich, J.P., I. Sherman, and G. Broze. 1987. Absença of thrombosis in subjects with heterozygous protein C Deficiency. N. Engl. J. Med. 317:991-996.
41. Hutchison, D.C.C. 1988. Natural history of alpha-1-protease inhibitor deficiency. Am. J. Med. 84: 3-12.
42. Guay-Woodford, L.M., G. Muecher, S.D. Hopkins, E.D. Avner, G.G. Germino, A.P. Guillot, J. Herrin, R. Holleman, D.A. Irons, W. Primack, P.D. Thomson, F. B. Waldo, P.W. Lunt, and K. Zerres. 1995. The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: Implications for genetic counseling. Am. J. Hum. Genet. 56:1101-1107.
43. Liu, A.W., A.V. Delgado-Ezcueta, J.M. Sarratoda, M.E. Alonso, M.T. Medina, M.N. Gee, S. Cordova, H.Z. Zhao, J.M. Spellman, J.R. Ramos Peek, F. Rubio Donnadieu, and R.S. Sparkes. 1995. Juvenile myoclonic epilepsy locus in chromosome 6p21.2-p11: linkage to convulsions and electroencephalography trait. Am. J. Hum. Genet. 57:368-381.
44. Peltonen, L. 1995. All out for chromosome 6. Nature (Lond.). 378:665-666.
45. Kato, K., G.D. Clark, N.G. Bazan, and C.F. Zorumski. 1994. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature (Lond.). 367:175-179.
46. Bazan, N.G. 1995. A signal terminator. Nature (Lond.). 374:501-502.